Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 97.7 USD -0.54%
Market Cap: 8.5B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

HQY Price Targets Summary
Healthequity Inc

Wall Street analysts forecast HQY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HQY is 114 USD with a low forecast of 94.94 USD and a high forecast of 136.5 USD.

HQY Lowest Forecast
Wall Street Target
94.94 USD
3% Downside
HQY Average Forecast
Wall Street Target
114 USD
17% Upside
HQY Highest Forecast
Wall Street Target
136.5 USD
40% Upside
Lowest
Price Target
94.94 USD
3% Downside
Average
Price Target
114 USD
17% Upside
Highest
Price Target
136.5 USD
40% Upside
Healthequity Inc Competitors:
Price Targets
HAPV3
Hapvida Participacoes e Investimentos SA
57% Upside
MOH
Molina Healthcare Inc
13% Upside
CLOV
Clover Health Investments Corp
17% Upside
ODPV3
Odontoprev SA
10% Upside
HAPV3
Hapvida Participacoes e Investimentos SA
57% Upside
MOH
Molina Healthcare Inc
13% Upside
CLOV
Clover Health Investments Corp
17% Upside
ODPV3
Odontoprev SA
10% Upside

Revenue
Forecast

Revenue Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 27%. The projected CAGR for the next 3 years is 10%.

27%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 32%.

22%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-33%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Healthequity Inc

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 18%. The projected CAGR for the next 3 years is 69%.

18%
Past Growth
69%
Estimated Growth
Estimates Accuracy
-65%
Average Miss
What are analyst estimates?

See Also

Summary
HQY intrinsic value, competitors valuation, and company profile.
DCF Valuation
HQY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HQY stock valuation using valuation multiples.
Wall Street Estimates
HQY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HQY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HQY's stock price target?
Price Target
114 USD

According to Wall Street analysts, the average 1-year price target for HQY is 114 USD with a low forecast of 94.94 USD and a high forecast of 136.5 USD.

What is Healthequity Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Healthequity Inc's revenue is 27%. The projected CAGR for the next 3 years is 10%.

What is Healthequity Inc's Operating Income forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Healthequity Inc's operating income is 22%. The projected CAGR for the next 3 years is 32%.

What is Healthequity Inc's Net Income forecast?
Projected CAGR
69%

For the last 8 years the compound annual growth rate for Healthequity Inc's net income is 18%. The projected CAGR for the next 3 years is 69%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 255,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.